Cancer Stock News: $BCTX The Bria-IMT regimen has received Fast Track Designation from US FDA - “Positive clinical data from our Phase 2 study reinforce our confidence in our pivotal Phase 3 study in metastatic breast cancer.”
NEWS:
https://globenewswire.com/news-release/2025/1...-2025.html